These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28176204)

  • 1. Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives.
    Hunter JE; Arnold KA; Cook JE; Zepp J; Gilmore MJ; Rope AF; Davis JV; Bergen KM; Esterberg E; Muessig KR; Peterson SK; Syngal S; Acheson L; Wiesner G; Reiss J; Goddard KAB
    Fam Cancer; 2017 Jul; 16(3):377-387. PubMed ID: 28176204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.
    Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA
    Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach.
    Morrison J; Bronner M; Leach BH; Downs-Kelly E; Goldblum JR; Liu X
    Scand J Gastroenterol; 2011 Nov; 46(11):1340-8. PubMed ID: 21879804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
    Schofield L; Goldblatt J; Iacopetta B
    Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities.
    Vindigni SM; Kaz AM
    Dig Dis Sci; 2016 Apr; 61(4):969-76. PubMed ID: 26602911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study.
    Li D; Hoodfar E; Jiang SF; Udaltsova N; Pham NP; Jodesty Y; Armstrong MA; Hung YY; Baker RJ; Postlethwaite D; Ladabaum U; Levin TR; Corley DA; Bergoffen J
    Ann Intern Med; 2019 Jul; 171(1):19-26. PubMed ID: 31181578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
    J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal Screening for Lynch Syndrome Compared with Pedigree-Based Screening: 10-Year Experience in a Tertiary Hospital.
    Kim MH; Kim DW; Lee HS; Bang SK; Seo SH; Park KU; Oh HK; Kang SB
    Cancer Res Treat; 2023 Jan; 55(1):179-188. PubMed ID: 35313100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer.
    Siraj AK; Prabhakaran S; Bavi P; Bu R; Beg S; Hazmi MA; Al-Rasheed M; Al-Assiri M; Sairafi R; Al-Dayel F; Al-Sanea N; Uddin S; Al-Kuraya KS
    Cancer; 2015 Jun; 121(11):1762-71. PubMed ID: 25712738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer.
    Eiriksson L; Aronson M; Clarke B; Mojtahedi G; Massey C; Oza AM; Gallinger S; Pollett A; Mackay H; Bernardini MQ; Ferguson SE
    Gynecol Oncol; 2015 Feb; 136(2):311-6. PubMed ID: 25529831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome.
    Katz LH; Burton-Chase AM; Advani S; Fellman B; Polivka KM; Yuan Y; Lynch PM; Peterson SK
    Clin Genet; 2016 Mar; 89(3):392-8. PubMed ID: 26272410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care survey.
    Barrow P; Green K; Clancy T; Lalloo F; Hill J; Evans DG
    Clin Genet; 2015 Jun; 87(6):517-24. PubMed ID: 25652327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worldwide variation in lynch syndrome screening: case for universal screening in low colorectal cancer prevalence areas.
    Kunnackal John G; Das Villgran V; Caufield-Noll C; Giardiello F
    Fam Cancer; 2021 Apr; 20(2):145-156. PubMed ID: 32914371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
    Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
    Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome.
    Musulén E; Sanz C; Muñoz-Mármol AM; Ariza A
    Hum Pathol; 2014 Jul; 45(7):1388-96. PubMed ID: 24768606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underutilization of Lynch Syndrome Screening at Two Large Veterans Affairs Medical Centers.
    Mittal C; Dang D; Stoffel E; Menees S; Scott FI; Ahnen D; Patel SG
    Dig Dis Sci; 2020 Nov; 65(11):3305-3315. PubMed ID: 32500284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer survivors' interest in genetic testing for hereditary cancer: implications for universal tumor screening.
    Cragun D; Malo TL; Pal T; Shibata D; Vadaparampil ST
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):493-9. PubMed ID: 22224634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience.
    Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS
    Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What would I do? Perspectives on the factors underlying Lynch syndrome genetic testing and results sharing decisions for high-risk colorectal cancer patients.
    Tiernan G; Freeman V; Morrow A; Hogden E; Canfell K; Kang YJ; Taylor N
    Psychooncology; 2022 Apr; 31(4):587-596. PubMed ID: 34698409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.